Introduction
The identification of aquaporins (AQPs), highly conserved membrane protein channels that are permeated by water, revised the general view on water passage across biomembranes as being solely the result of passive diffusion across the lipid bilayer. 1,2 The last decade contributed greatly to the understanding of the diverse roles of AQPs in health and disease. Particularly, the ability of AQPs to permeate not only water but also other small molecules or solutes, enables them to regulate several cell functions, which include osmotic water movement in cell volume regulation, energy metabolism, migration, adhesion and proliferation. [3] [4] [5] [6] Presently, thirteen mammalian AQP isoforms (AQP0-12) have been identified, ubiquitously distributed throughout the body. Based on structural and functional characteristics, these channel proteins are divided into two main groups: orthodox aquaporins strictly involved in water permeability (APQ0-2, AQP4, AQP5, AQP6 and AQP8) and aquaglyceroporins, facilitating transport of small uncharged solutes such as glycerol and urea, additionally to water (AQP3, AQP7, AQP9, and AQP10). 7 Peroxiporins are a further subclass of AQPs permeable to hydrogen peroxide, and comprise both orthodox aquaporins (AQP1, AQP8) and aquaglyceroporins (AQP3 and AQP9). Finally, due to their subcellular localization, AQP11 and AQP12 are classified as S-aquaporins. 8, 9 The nature of selective permeability for the latter is still uncertain and they show less sequence similarity to the other isoforms. However, there are indications of AQP11 facilitating water and glycerol transport. 10, 11 Pathophysiological conditions of numerous human disorders have been correlated with altered aquaporin function as a result of dys-, up-or down-regulated AQPs expression (Fig. 1) . 12 Nephrogenic diabetes insipidus and Sjörgens syndrome are just two examples of disorders linked to impaired water permeability of AQPs. 13 The d sfu tio of a uagl e opo i s a ilit to permeate glycerol, as well as their abnormal expression in certain tissues, have consequences for cell proliferation, adipocyte metabolism and epidermal water retention. Thus, aquaglyceroporins seem to play a role in metabolic disorders such as obesity, diabetes and skin diseases, e.g. atopic dermatitis. 14, 15 Interestingly, studies report isoforms of both orthodox aquaporins and aquaglyceroporin linked to different types of cancer, often showing a strong correlation between the level of AQP expression and the tumour grade. 5, [16] [17] [18] Notably, parasite aquaglyceroporins are also relevant to certain human diseases, such as malaria. 19 Since aquaporins are involved in a variety of important physiological and pathophysiological processes, they have gained increasing attention as promising targets for therapeutic intervention.
However, discovering selective AQPs modulators (inhibitors) proved to be challenging. Such inhibitors would not only be useful as novel therapeutic agents but also as chemical probes to validate AQPs function in biological systems, to be used in parallel to genetic approaches (e.g. knockout animal models). After presenting a general overview on AQP structure and expression in both healthy and tumour tissue, this perspective will focus on the role of AQPs in tumorigenesis and tumour metabolism and summarize the state-ofthe-art literature on the most promising AQP-targeted metal-based inhibitors highlighting their possible uses in medicine and cancer pathophysiology.
Aquaporin structure
Aquaporins are homo-tetrameric complexes in the cell membrane, with each monomer of ~ 30 kDa containing six transmembrane -helices connected by five loops, two half helices and both N-and Ctermini located on the cytoplasmic side of the membrane. 20, 21 Two of the loops are located intracellularly while three are extracellular domains. 20 Each AQP monomer in the membrane creates a single narrow hourglass-shaped pore spanning the lipid bilayer (Fig. 2) . 22 Specific features of this channel are essential to the remarkable selective nature of AQPs for permeation of water and other small solutes, namely two highly conserved constriction sites acting as selectivity filters. 4, 20 The constriction site located near the extracellular entrance is known as the aromatic/arginine selectivity filter (ar/R SF) (Fig. 2 ) and the diameter of this filter determines whether small polar solutes may permeate the pore in addition to ate . I o thodo a uapo i s the po e s dia ete at the ar/R SF is ca. 3 Å, preventing permeation of molecules bigger than water (2.8 Å). 20 The size of the pore is larger in aquaglyceroporins, reaching up to ~3.4 Å in diameter to allow for example glycerol permeation. 21, 23, 24 Although the arginine in this constriction site is fully conserved in all mammalian AQPs isoforms, the composition of the remaining amino acids creating the ar/R SF might vary depending on the permeability for water or glycerol. Orthodox aquaporins have an ar/R SF formed by four residues, while aquaglyceroporins have an ar/R SF formed by only three residues, which most likely accounts for the different pore sizes and selectivity. 21 The second selectivity filter is composed of two conserved asparagine-proline-alanine (NPA) motifs, located in the centre of the channel where the positive N-terminal ends of the two half helices meet. The formed helix dipole moment adds to these positive ends, creating an electrostatic barrier that prevents the passage of positively charged ions through the pore. 25 Particularly the Asn side chain amide position appears to be structurally critical to this functionality, whilst the amide nitrogens aid in directing water or solute molecules by acting as hydrogen bond donors. 26 Molecular dynamics (MD) simulations, electron microscopy and X-ray crystallographic structures of AQPs revealed water molecules passing through the channel in a single file, orienting themselves along the local electrical field. 23, 27 Unlike the previously mentioned structural difference found between AQPs and aquaglyceroporins in the ar/R SF, the NPA region is conserved in most human AQP isoforms, with the exception of AQP7 (NAA-NPS), AQP11 (NPC-NPA) and AQP12 (NPT-NPA). However, all AQPs preserve the Asn residue, thus emphasizing its importance. 
Aquaporins in normal and tumour physiology
Numerous studies observed a correlation between AQP expression levels in cancer cells and cancer malignancy. 5, 16, 28 However, this observation does not imply that only one type of AQP relates to a specific cancer. In fact, multiple AQP isoforms were reportedly involved in tumours at different stages. 16, 29 Interestingly, some tumours also showed up-regulated expression of AQPs isoforms which are usually not found in the tissue of origin. Table 1 provides an overview of the presence of different AQP isoforms in various human cancer types (studied in cells or tissue samples) and possible related functions. The involvement of aquaporins in tumours can be partially dependent on the nature of their substrate permeability, as will be explored further in the next sections. Thus, here we will summarize some of the studies that best describe the function of different AQPs isoforms in cancer development.
Water permeation
The presence of AQPs in human tissues facilitates water permeation across the membrane, allowing fast cellular responses to changes in the osmotic gradient. Therefore, AQPs are abundantly present in tissues involved in maintaining water-based homeostasis, with a need for rapid fluid turnover such as the kidneys (AQP1, AQP2, AQP3, AQP4), 30 
Migration of tumour cells
The ability of tumour cells to migrate enables tissue invasion and metastasis, which are both associated with a poor prognosis. 83 AQPs 1, 4 and 5 are the main AQP isoforms shown to be involved in general cell migration. Under normal physiological circumstances, AQP1 expression is polarized on the leading edge of cell protrusions in migrating cells, which is hypothesized to enhance the process of cell movement. 34 The increased water permeability combined with actin cleavage and ion uptake at the tip of the lamellipodia create local osmotic gradients, which drive water influx and ultimately enable lamellipodia extension and cell migration. 34, 84 It was suggested that
AQPs facilitate the rapid changes in cell shape that take place as a migrating cell squeezes through the extracellular matrix. Such cell volume changes are likely to require rapid water flow in and out of the cell, thus justifying the presence of AQPs water channels. Interestingly, detecting the expression levels of AQP4 to distinguish benign from malign thyroid nodules was the claim of a recent patent. 89 The invention is based on the discovery that AQP4
immunostaining of suspected follicular neoplasm can facilitate the distinction of benign from malign oncocytic lesions, and it seems useful in deciding which thyroid nodules should be dissected or removed in thyroid surgery. 89 Concerning AQP5, its upregulation was linked in several tumours to enhanced migration and invasive phenotypes. 65, 90 In fact, overexpression of this isoform has been correlated with lymph node metastases in ovarian 64 , prostate 68 , colon 39 , cervical 40 , lung 63 and oesophageal 51 cancers. In lung cancer cells in vitro, AQP5 overexpression was associated with increased cell migration, while AQP5 knockdown led to decrease in cell migration and invasion properties. 71 A similar effect was observed in the migration of gastric carcinoma 70 cells and invasion of breast cancer cells 65 . Another in vitro study, using human glioma cells showed that increased AQP5 mRNA expression was positively correlated with proliferation rates and silencing inhibited cell proliferation, reduced migration and promoted cell apoptosis. 91 Recently, the role of AQP5 in hepatocellular carcinoma metastasis was also evaluated. 92 The authors showed that AQP5 was highly expressed in hepatocellular carcinoma cell lines a d its do egulatio i hi ited the ells capacity of invasion and metastasis, both in vitro and in vivo.
Tumour oedema
Upregulation of AQPs as water channels may also contribute to oedema formation and patients with tumour oedema in the brain display an increased morbidity and mortality rate. 32 For example, AQP1 was found upregulated in glioblastomas, enhancing the water permeability in perivascular areas like the blood-brain barrier. 37, 93 Based on these studies, AQP1 has the potential to be applied as a survival prognosticator in glioblastoma. 94 Over-expression of AQP4
was also associated with tumour oedema in the brain. 36 However, due to the upregulation of AQP4 in the peritumoral area rather than the tumour core, its involvement in migration might be even more relevant. 95 Subsequent experiments showed that AQP4 deletion in mice increased oedema around implanted melanoma in the brain, suggesting that the increased AQP4 expression by reactive astrocytes in and around the tumour facilitate elimination of brain oedema fluid. 96
Glycerol transport
Concerning aquaglyceroporins (AQPs 3, 7, 9, 10 and 11) and their roles in physiology, as expected their expression is particularly high in tissues involved in glycerol metabolism such as adipocytes and liver, and thus, influences metabolic pathways. 97, 98 Circulating glycerol derives from fat lipolysis, glycerol absorbance from the strointestinal tract or re-absorbance in the proximal tubules in the kidneys. 99 Glycerol is an important intermediate in gluconeogenesis, lipid metabolism and in an electron shuttle system into mitochondria. The latter carries reducing equivalents from the cytosol to mitochondria for oxidative phosphorylation. 100 Depending on the cellular energy status, metabolism can take place in the outer mitochondrial membrane.
In the body, glycerol is stored in adipose tissue in the form of triacylglycerol (TAG), which may derive from glycolysis. The TAG precursors are CoA-activated fatty acids and glycerol-3-phosphate (G-3-P), produced either from the reduction of dihydroxyacetone phosphate (DHAP) or the phosphorylation of glycerol. 101 Adipose tissue or muscles do not express glycerol kinase (GK), the enzyme required for glycerol phosphorylation, which is why they acquire G-3-P from glycolysis. AQP7 is the primary glycerol transporter in adipose tissue and abundantly expressed in the plasma membrane of adipocytes (Fig. 3 ). 102 However, recently, AQP11 has also been identified in human adipocytes in the vicinity of lipid droplets and to be able to permeate glycerol. 10 Under fasting conditions, glycerol released by adipose tissue upon lipolysis is taken up by the liver, most likely via AQP9, 79 and used as a non-carbohydrate precursor to induce gluconeogenesis in hepatocytes. 101 Thus, AQP7 seems to facilitate glycerol efflux from adipose tissue, leading to glycerol influx into hepatocytes via AQP9. 102, 103 Similarly to the orthodox aquaporins, aquaglyceroporins are also involved in osmoregulation. In fact, glycerol is one of the main osmoprotective solutes in mammalian cells. 100 In response to external gradients, cells can react by altering intracellular levels of glycerol whilst reducing or increasing membrane permeability. Like water, glycerol can cross the lipid bilayer via passive diffusion.
However, this process is relatively slow and the presence of aquaglyceroporins highly increases glycerol permeability, turning glycerol permeation into a faster and more energy efficient process.
In the skin, AQP3 is the most abundantly expressed isoform, in particular in keratinocytes residing in the basolateral layer of the epidermis. 104 Under physiological conditions, water and glycerol are essential in preserving skin moisture. Glycerol acts as a humectant to prevent water evaporation, thus upholding the barrier function of the skin. 105 In mice, deletion of AQP3 was shown to impair this barrier function by reducing elasticity and hydration, as well as showing delayed wound healing and reduced cell proliferation in the stratum corneum. 106
Fig. 3
Aquaglyceroporins and glycerol metabolism in liver and adipose tissue. Abbreviations: G-3-P = glycerol 3-phosphate, DHAP = dehydroxyacetone phosphate, TCA = tricarboxylic acid, FFA = free fatty acid, TAG = triacylglycerol, MAG = monoacylglycerol.
Glycerol in cancer cell proliferation
Overall, the experimental evidence describing increased aquaglyceroporin expression in tumours (Table 1) Below we will summarize the studies that corroborate these hypotheses on the interplay between glycerol and cancer.
Out of the four human aquaglyceroporin isoforms, AQP3 is the most studied also in relation to cancer. This isoform is widely distributed throughout the body in epithelial cells. 105, 107 A recent study by our group, showed that AQP3 inhibition reduced cell proliferation as a function of the AQP3 expression levels in different cell lines, including cancer cells. 108 Furthermore, it was found that AQP3 silencing induced downregulation of several lipid synthases in gastric cancer cells in vitro. 109 Thus, it was postulated that lipid synthesis impairment by AQP3 knockdown is not only the consequence of glycerol uptake decrement but also related to lipid synthesis system inhibition. The PI3K (phosphatidylinositol-4,5-bisphosphate 3-kinase) /Akt (protein kinase B) signalling pathway, which was involved in the impaired lipid and ATP production, was also inhibited after AQP3 knockdown. 109 As cancer cells divide at higher rates, they require more lipids for membrane synthesis, and more energy to sustain the vigorous proliferation and the malignant behaviour. In fact, phospholipids are used to form the various plasma membranes, but can also be catabolized to generate ATP β-oxidation. 110, 111 As previously mentioned, glycerol can be metabolized to be the backbone of triglyceride (TAG), and TAG is important in maintaining cell proliferation and survival. Specifically, tumour cells can convert TAG into free fatty acid (FFA) by lipolytic processes (Fig. 4) . Fatty acid oxidation (FAO) is used to generate ATP to support the cancer development. 112 Thus, inhibition of lipid synthesis, via aquaglyceroporins inhibition or down-regulation, may result in material and energy supply defects.
The second main hypothesis for the role of AQP3 in tumour cell migration and proliferation relates to the fact that its overexpression provides the cell with higher glycerol permeability leading to higher ATP content, 113 required for a greater demand for biosynthesis. This idea of a direct correlation between glycerol and ATP production was developed in 2008, when Hara-Chikuma and
Verkman observed a remarkable resistance to skin tumorigenesis in AQP3-deficient mice. 59 Their data suggested that glycerol permeability via AQP3 is required for epidermal cell proliferation and tumorigenesis, as the cellular glycerol levels were positively correlated with cellular ATP content. 59 In detail, a reduction of glycerol in epidermal cells, its metabolite G-3-P, and ATP were observed in AQP3-deficiency without impairment of mitochondrial function. 59 Glycerol supplementation corrected the reduced proliferation and ATP content under AQP3 deficiency. Thus, it was suggested that glycerol could be a key regulator of cellular ATP, which could justify the overexpression of AQP3 in some cancers.
However, this hypothesis needs some careful reflection on the biochemical pathways possibly linking glycerol to ATP synthesis, particularly in relation to cancer cell metabolism. In general, tumours display a deregulated metabolism to meet the high demand for nutrients used to support cell proliferation and survival, while maintaining a balanced redox status. 114 Thus, in cancer, glucose and glutamine are often the main energy sources. 115, 116 In the early 20s, Warburg theorized that impaired mitochondrial respiration would drive tumorigenesis and cause an increased consumption of glucose, reflected in high lactate production, i.e. aerobic fermentation, named the Warburg effect. 117 However, current research challenges this interpretation postulating that tumours retain their capacity to perform oxidative phosphorylation, even within the hypoxic environment, and metabolic changes are rather an effect of various malignant cellular transformations than a cause of tumorigenesis. 114, 118 Proliferating cancer cells have an increased need for precursors and intermediates for biosynthesis and reducing equivalents, which the catabolism of glucose and glutamine can provide. 118 Oxidation of carbon skeletons, produced from glucose, allows the cells to capture the electrons in the form of reduced nicotinamide adenine dinucleotide (NADH), which are then introduced into the mitochondrial electron transport chain via the malate-aspartate
shuttle. This process contributes to cellular respiration and ATP generation. 118 Proliferating tumour cells seem to prefer converting excess pyruvate into lactate, which contributes to maintaining the cytoplasmic level of the NAD + /NADH ratio to promote a continued glucose metabolism. 118, 119 In this context, tumours overexpressing aquaglyceroporins are thought to use glycerol as an intermediate for pyruvate through the glycerol 3-phosphate shuttle (G-3-P shuttle) leading to ATP production (Fig. 4) . The G-3-P shuttle is a complex process used to transfer electrons from cytosolic NADH to the mitochondrial electron transport chain (Fig. 4) . 120 In this shuttle, the enzyme called cytoplasmic glycerol-3-phosphate dehydrogenase 1 (cGPDH)
converts dihydroxyacetone phosphate to G-3-P by oxidizing one molecule of NADH to NAD + , whilst the mitochondrial glycerol-3-phosphate dehydrogenase (mGPDH) converts G-3-P to DHAP by reducing flavine adenine dinucleotide (FAD + ) 120 This system regenerates cytosolic oxidized nicotinamide adenine dinucleotide (NAD + ) and supports oxidative phosphorylation in mitochondria, thus production of adenosine triphosphate (ATP). In humans, the G-3-P shuttle functions mainly in the brain and skeletal muscle. 101 In proliferating cells, glycerol phosphorylation is catalysed by Glycerol Kinase (GK), converting glycerol to G-3-P. 100 The G-3-P can either be utilized in the biosynthesis of phospholipids as an important structural component of cellular membranes or enter the glycolytic pathway, when converted to DHAP by mGPDH. 100, 101, 121 However, the latter is less likely to occur, as proliferating cells interconvert DHAP to G-3-P in order to re-oxidize cytosolic NADH generated from glycolysis, transferring reducing equivalents into the electron transport chain. The enzyme mGPDH shows an increased activity in prostate cancer cells, melanoma and breast cancer, thought to uphold glycolysis and facilitating the oxidation of NADH. 122 It is important to recognize that cancer cell metabolism is continuously adapting and reprogramming to optimize the use of available nutrients. Overall, although glycerol is more likely to contribute to tumour cell growth as a precursor for phospholipids, its interplay in the generation of ATP cannot be ruled out, and this aspect would warrant further investigation.
Despite AQP3 being the most studied isoform in relation to cancer, all other aquaglyceroporins have been shown to be expressed in cancer tissue, with an established correlation to several types of cancers (Table 1) .
For example, immunostaining of AQP7 in epithelial ovarian cancer showed expression in the plasma membranes of benign tumour cells, while being located in the nuclear membrane of borderline and malignant cells. 80 Interestingly, despite the selective nuclear staining in malignant tumour tissue, western blot analysis of protein levels showed that AQP7 is significantly higher in malignant and borderline tumour than in benign tumour and normal ovarian tissue. This indicates that translocation and expression of this isoform may be crucial for ovarian carcinogenesis.
AQP9 has been shown to be in human glioblastoma, most glioma cells showing high AQP9 protein expression on the cell surface. 123 Other authors have shown that AQP9 mRNA is present in specific subpopulations of glioma cells and leukocytes infiltrating the tumour tissue. 124 Moreover, work by Fossdal et al. revealed that AQP9 mRNA and protein expression is increased in glioblastoma stem cells. 125 Expression of this isoform in glioblastoma may indicate a role in glioma-associated lactic acidosis, by facilitating glycerol and lactate excretion, and/or being involved in the energy metabolism of glioma cells. This example highlights the crucial role of AQPs not only in glycerol uptake but also in regulating its efflux (Fig. 4) . In epithelial ovarian cancer, AQP9 was shown to be localized in the basolateral membranes of both benign and borderline tumour cells, while it was widely distributed throughout membranes of malignant cells. 80 Moreover, protein expression analysis by western blot revealed that there is a significant difference between tumour types as follows:
ovarian malignant > borderline > benign/normal tissue. Interestingly, AQP9 was shown to be higher expressed in mucous than serous ovarian tumours and also correlated with tumour grade: higher expression in undifferentiated (grade 3) than well differentiated (grade 1/2) tumours. 78, 80 Therefore, increased AQP9 expression may be related to poor prognosis, highlighting once more the importance of understanding the role of aquaglyceroporins and glycerol in carcinogenesis.
Interestingly, AQP9 was shown to be down-regulated in hepatocellular carcinoma. 81 Moreover, its overexpression suppressed cell invasion, both in vitro and xenograft tumour growth, as well as hepatoma cell invasion by inhibiting epithelial-tomesenchymal transition. This fact clearly shows that the role of aquaglyceroporins in cancer development may differ according to specific tissue types a d the tissue s e ui e e t of eithe gl e ol uptake or efflux.
Little is known about the role and expression of AQP10 and 11 in cancer. One study, that used microarray data to investigate prognostic values of AQP mRNA expression in human ovarian cancer,
showed that AQP3, 10 and 11 are correlated with improved overall survival in ovarian cancer patients. 126 However, nothing is known about the protein expression of AQP10 and 11 in cancer cells or tissues.
Finally, while the correlation of aquaglyceroporins with several types of cancers is established ( Thus, the requirement for glycerol might decrease, as the focus shifts from tumour proliferation to migration.
The possible role of AQP3 downregulation as an indicator for the invasive character was also observed in prostate tumours. 127 These findings are supported by Jain. et al., who examined consumption and release of 219 metabolites in the medium of the 60 cell lines of the NCI-60 screen. 115 Their results suggest increased consumption of glycerol in some non-metastatic over metastatic cancer cell lines.
Overall, it is important to note that glycerol requirements may vary with the specific tissue of origin, malignancy, differentiation and metastatic properties, making aquaporins very challenging to study.
Furthermore, due to AQPs bi-directio alit of pe eatio , tu ou s need to control glycerol uptake or efflux may lead to decreased expression of particular isoforms.
Hydrogen peroxide transport
Similarly to water, H2O2 was originally thought to freely cross the cell membrane by means of passive diffusion. However, experimental studies suggested rapid diffusion through the lipid bilayer was likely facilitated by membrane protein like AQPs. [128] [129] [130] Currently, there is evidence for H2O2 permeation by AQP3, 131 AQP8 132 and AQP9 133 , while hydrogen peroxide permeation of AQP1 is still controversial. 130, 131 Since isoforms from both orthodox AQPs and aquaglyceroporins have hydrogen peroxide as a substrate, they are also referred to as peroxiporins. AQP3 and AQP9 can both be found in the plasma membrane, whereas AQP8, in addition to its plasma membrane localization, is also present in the inner membrane of mitochondria, which are a major source of reactive oxygen species (ROS) in animal and plants. 134 For example, Marchissio et al.
examined whether knockdown of mitochondrial AQP8 (mtAQP8) in human hepatoma cells using siRNA had an effect on mitochondrial H2O2 efflux. 135 The authors found that, compared to wild-type mitochondria, isolated mtAQP8 knockdown mitochondria had a lower H2O2 efflux ability, while the cells suffered from reduced viability. Hydrogen peroxide is part of the ROS that comprise superoxide, superoxide radicals and hydroxyl radicals. In healthy cells, ROS play a significant role in maintaining homeostasis, where intra-and extracellular concentrations of ROS are controlled using scavenging systems to balance ROS generation and elimination. 136 ROS are generated as a by-product of aerobic metabolism, with nicotinamide adenine dinucleotide phosphate oxidases (NOX) and the mitochondrial electron transport chain (mETC) as the main sources. 137 unfortunately shows a large variation in susceptibility. 150, 151 After intravenous administration, the ascorbate readily generates extracellular H2O2, which permeates the cancer cell membrane and accumulate intracellularly, ultimately inducing cell death due to excessive ROS. 152 The latest findings by Erudaitius et al. suggested that the success of pharmacological ascorbate treatment of pancreatic cancer may depend on peroxiporin (AQP3) expression. 153 Besides AQP3, AQP8 and AQP9, other isoforms are still explored as potential peroxiporins. AQP5, for example, is an interesting candidate due to its association with ERG and PTEN in prostate cancer, 154 with EGFR/ERK in human glioma cell lines, 91 and in hepatocellular carcinoma metastasis with NF-κB 92 . Interestingly, a recent study on rat AQP5 showed its ability to facilitate H2O2 membrane diffusion in yeast. 155 Thus, more research should be conducted to elu idate AQP5 s possi le ole as pe o iporin in human cancers.
Aquaporin Inhibitors
As highlighted above, there is strong evidence for AQPs as drug reported. Thus, in the following chapters, we will focus on the most promising metal-based AQPs inhibitors and their possible mechanisms of action described at a molecular level.
AQPs inhibition by metal ions
In normal physiology, AQPs can be regulated by various factors, including protein phosphorylation, pH and metal ions. The latter are mainly divalent cations, such as first-row transition metals, some of them being physiologically relevant. For example, Zelenina et al.
have investigated the effects of Ni 2+ (NiCl2) on the water permeability of AQP3 in human lung epithelial cells, showing that it is capable of decreasing permeability to only 30%, at a concentration of 1 mM after 1 min of incubation. 157 The inhibition was shown to be reversible and Ni 2+ did not have any effect on AQP4 or AQP5.
Later, the same authors studied the effects of Ni 2+ (as NiCl2) and Cu 2+
(as CuSO4) on glycerol permeability and found that both ions reduce AQP3 permeability at a concentration of 1 mM in HEPES buffer. 158 Interestingly, Pb 2+ and Zn 2+ ions had no effect on AQP3 permeability.
Furthermore, AQP7, another aquaglyceroporin, was insensitive to copper.
Zelenina et al. have also investigated which amino acid residues are involved in the inhibitory mechanism of both Ni 2+ and Cu 2+ ions by site-directed mutagenesis, and suggested serine, histidine and tryptophan residues as possible binding sites. 157, 158 Interestingly, Ser152 was identified as a common determinant of both Ni 2+ /Cu 2+ and pH sensitivity. All these residues are in the extracellular loops of the AQP3 monomers, and loop movement was observed in the gati g e ha is of se e al AQPs and appears to be a crucial feature in channel closure. [159] [160] [161] For example, histidine residues in su h loops a tu e the pH se siti it of AQP3 towards certain pH values, as suggested by molecular modelling. 162 Among the benchmark AQPs inhibitors, the mercurial compounds pCMBS (p-chloromercurybenzene sulphonate) and HgCl2
have been widely applied in in vitro biochemical assays to study AQPs function, despite their scarce selectivity and extreme toxicity. The mechanism of inhibition involves direct binding of Hg 2+ ions to AQPs via modification of cysteine residues based on the classical hard soft acids and bases (HSAB) theory. In order to confirm such mechanism, several studies were performed on Cys-mutated isoforms of human AQP1. For example, Xenopus oocytes were transfected with Cysmutated AQP1 isoforms and the effects of mercury inhibition were evaluated. 163 From all cysteine residues in AQP1, only one was shown to confer sensitivity to the mercurial salt HgCl2, namely Cys189.
When this cysteine is mutated to either serine or glycine, water permeability of the oocytes was slightly decreased, indicating that this residue may be of importance for water transport. Moreover, cells expressing the Cys189Ser mutant lost sensitivity to HgCl2.
The current literature provides two mechanisms of inhibition of AQPs by mercury: the first is simple occlusion of the water pore by the mercury ions found in the vicinity of the cysteine residues lining the pore; the second is conformational change (collapse of the water pore) at the selectivity filter (namely, the (ar/R) SF) region, induced by mercury bound to a cysteine residue nearby.
The first hypothesis was formulated after the atomic-resolution structure of human AQP1 was solved, where Cys189 was shown to be positioned inside the channel, just above the ar/R SF. 27 Therefore, it was hypothesized that Hg 2+ binding to this site was likely to prevent passage of water molecules via steric effects.
The second mechanism of AQP inhibition by mercurial compounds was first proposed in an in silico study on the basis of molecular dynamics (MD) simulations of the bovine aquaporin AQP1 (bAQP1). 164 bAQP1 contains a cysteine residue (Cys191) in the ar/R SF region, which may bind Hg 2+ similarly to hAQP1. According to the MD simulations of both free AQP1 and Hg-bound AQP1, the energy barrier for Hg-AQP1 is much higher than that of free AQP1 at the ar/R SF. Moreover, calculations show that mercury binding induces a collapse of the orientation of amino acid residues at the ar/R SF and the constriction of the space between Arg197 and His182.
Later on, our group investigated the molecular mechanism of inhibition of human AQP3 by Hg 2+ , using MD approaches. 165 In support of the second mechanistic hypothesis, we observed important protein conformational changes upon binding of metal ions to Cys40 leading to a collapse of the ar/R SF, and subsequent blockage of water permeation. In a further stud , ou g oup e a i ed Auphe s apa it of inhibiting cell proliferation in various cell lines with different levels of AQP3 expression. 108 Our results showed a direct correlation between AQP3 expression levels and the inhibition of cell growth by the gold(III) compound. Functional studies also demonstrated AQP3 inhibition in the cell lines where proliferation was affected by treatment with the gold compound.
Gold complexes as inhibitors of aquaglyceroporins
Using molecular modelling approaches, we investigated the noncovalent binding of Auphen to AQPs at a molecular level and found that its isoform selectivity is due to the accessibility to Cys40, whose thiol group is a likely candidate for direct binding to Au(III)
complexes. 166 The involvement of this residue in the inhibition mechanism was further confirmed by site-directed mutagenesis studies in a subsequent study. 108 Additional results on other Au(III) compounds with different N^N ligand scaffolds allowed us to establish preliminary structure-activity relationships: the most effective compounds were those featuring at least one positive charge, one ligand that could be exchanged to allow metal coordination to protein residues, and aromatic ligands. 167 Unexpectedly Recently, MD studies were conducted for the first time on another potent and selective inhibitor -the compound [Au(1-methyl-2-(pyridin-2-yl)-benzimidazole)Cl2]PF6 (Au1, Fig. 6 ) -bound to Cys40 of AQP3 (Fig. 7) . The obtained results showed that protein conformational changes upon metal binding to Cys40, and not direct steric blockage of the channel by the metal compound, are mostly responsible for the observed inhibition of water and glycerol permeation (Fig. 8) . 168 These findings are in line with the above-mentioned studies on AQPs inhibition by mercury. Furthermore, binding of Au1 in one monomer also affects substrate permeability in an adjacent one, thus, altering the overall extracellular distribution of hydrophobic/hydrophilic surfaces of the tetramer, which, in turn, orients the approach of the substrates to the pore. Moreover, in this study, a correlation between the affinity of the Au(III) complex towards Cys binding and AQP3 inhibition was highlighted, while no influence of the different oxidative character of the metal complexes was observed. 168 Further investigation of another selective AQP3 inhibitor, the gold(III) cationic complex [Au(bipy)Cl2]PF6 (bipy = , -bipyridine, Aubipy, Fig. 6 ), bound to the protein channel, has been performed by means of a multi-level theoretical workflow that includes QM, MD and QM/MM approaches. 169 In this study, three key aspects for AQP3 Notably, in this latter study, we suggest that the presence of thiol binding sites in AQP3 is necessary but not sufficient to determine the selectivity of Aubipy. 169 Instead, the formation of stable noncovalent Aubipy-AQP3 adducts is required to compensate the thermodynamic and kinetic barriers associated with the formation of the final covalent Au-Cys adduct. In detail, the overall Aubipy-AQP3 binding process may be described as depicted in Fig. 9 . Overall, these results have important implications for future i hi ito s desig , showing that amino acid residues other than those lining the pore could be targeted, provided that their modification leads to the necessary conformational changes to achieve channel closure. In addition, careful fine-tuning of the interactions between the metal complex and specific residues at the pore extracellular entrance, leading to the formation of the first non-covalent adduct, may be achieved by different substituents on the ligand bound to Au(III), as well as by the use of different aromatic scaffolds (e.g., C^N-cyclometallated and benzimidazole ligands). In this way, one may increase the selectivity of the compound for inhibition of AQP3 compared with other aquaglyceroporin isoforms.
Selectivity of aquaglyceroporin inhibition is essential to deliver a targeted therapy, dependent on the isoform of interest. In fact, Auphen was also observed to inhibit AQP7 although with lower potency and different mechanism of inhibition, as indicated by permeability studies and molecular modelling approaches, respectively. 170 Specifically, whilst Cys residues corresponding to Cys40 in AQP3 are not available, several Met side chains are accessible, either on the extracellular or the intracellular side of human AQP7, for binding to Au(III) complexes.
The fact that the inhibition mechanism of the same compound with two different AQPs may be different, indicates that it is possible to take advantage of even small structural differences between the isoforms to optimize the inhibitor s he i al s affold a d, thus, to achieve selectivity.
Conclusions and Perspectives
Clinical and preclinical studies evidence that AQP expression is increased in a number of cancers. Therefore, in recent years, Finally, inorganic chemistry offers important advantages with respect to organic chemistry. For example, metal complexes constitute an ideal drug design platform, where not only the geometric properties of the molecule can be easily varied, but also offe i g the possi ilit of fine-tu i g the ea ti it of the compounds via appropriate liga ds hoi e, ai tai i g the AQPs inhibition activity while reducing the side-effects. 
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